Clinical efficacy of an α1A/D-adrenoceptor blocker (naftopidil) on overactive bladder symptoms in patients with benign prostatic hyperplasia

International Journal of Urology

Volumn 13, Issue 1, 2006, Pages 15-20

  Takahashi, Satoru ^a   Tajima, Atsushi ^b   Matsushima, Hisashi ^b   Kawamura, Takeshi ^b   Tominaga, Takashi ^b   Kitamura, Tadaichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

1A 1D blocker; Benign prostatic hyperplasia; Naftopidil; Nocturia; Overactive bladder

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; NAFTOPIDIL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; NAPHTHALENE DERIVATIVE; PIPERAZINE DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MALE; NOCTURIA; OVERACTIVE BLADDER; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; SAMPLE SIZE; SCORING SYSTEM; TREATMENT OUTCOME; TREATMENT RESPONSE; URGE INCONTINENCE; URINARY FREQUENCY; URINARY URGENCY; URINE VOLUME; UROFLOWMETRY; COMPARATIVE STUDY; FOLLOW UP; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY; URINE INCONTINENCE; URODYNAMICS;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; AGED, 80 AND OVER; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NAPHTHALENES; PIPERAZINES; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY INCONTINENCE; URODYNAMICS;

EID: 33645215690     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2006.01222.x     Document Type: Article

References (20)

1. Abrams P Cardozo L Fall M et al. The standardization of terminology of lower urinary tract function: report from the Standardization Sub-committee of the International Continence Society NeurourolUrodyn 2002 21 167 78
2. Stewart WF Van Rooyen JB Cundiff GW et al. Prevalence and burden of overactive bladder in the United States WorldJUrol 2003 20 327 36
3. Michel MC Kenny B Schwinn DA Classification of alpha 1-adrenoceptor subtypes Naunyn Schmiedebergs ArchPharmacol 1995 352 1 10
4. Michelotti GA Price DT Schwinn DA Alpha 1-adrenergic receptor regulation: basic science and clinical implications PharmacolTher 2000 88 281 309
5. Hampel C Dolber PC Smith MP et al. Modulation of bladder alpha1-adrenergic receptor subtype expression by bladder outlet obstruction JUrol 2002 167 1513 21
6. Malloy BJ Price DT Price RR et al. Alpha1-adrenergic receptor subtypes in human detrusor JUrol 1998 160 937 43
7. Takei R Ikegaki I Shibata K Tsujimoto G Asano T Naftopidil, a novel α1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human α1-adrenoceptors JpnJPharmacol 1999 79 447 54
8. Yasuda K Yamanishi T Tojo M et al. Effect of naftopidil on urethral obstruction in benign prostatic hyperplasia: assessment by urodynamic studies Prostate 1994 25 46 52
9. Weiss JP Blaivas JG Nocturia JUrol 2000 163 5 12
10. Lepor H Shapiro E Characterization of alpha 1 adrenergic receptors in human benign prostatic hyperplasia JUrol 1984 132 1226 9
11. James S Chapple CR Philips MI et al. Autoradiographic analysis of alpha-adrenoceptors and muscarinic cholinergic receptors in the hyperplastic human prostate JUrol 1989 142 438 44
12. Chapple CR Aubry ML James S et al. Characterization of human prostatic adrenoceptors using pharmacology receptor binding and localization BrJUrol 1989 63 487 96
13. Lepor H Auerbach S Puras-Baez A et al. A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia JUrol 1992 148 1467 74
14. Jensen D Jr. Uninhibited neurogenic bladder treated with Prazosin ScandJUrolNephrol 1981 15 229 33
15. Hieble JP Ruffolo R Recent advances in the identification of α1- and α2-adrenoceptor subtypes: therapeutic implications ExpOpinInvestDrugs 1997 6 367 70
16. Gu B Reiter JP Schwinn DA et al. Effect of α1-adrenergic receptor subtype selective antagonist on lower urinary tract function in rats with bladder outlet obstruction JUrol 2004 172 758 62
17. Nomiya M Yamaguchi O A quantitative analysis of mRNA expression of alpha1 and beta-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders JUrol 2003 170 649 53
18. Smith MS Schambra UB Wilson KH Page SO Schwinn DA Alpha1-adrenergic receptors in human spinal cord: specific localized expression of mRNA encoding alpha1-adrenergic receptor subtypes at four distinct levels MolBrain Res 1999 63 254 61
19. Sugaya K Nishijima S Miyazato M Ashitomi K Hatano T Ogawa Y Effects of intrathecal injection of tamsulosin and naftopidil, alpha-1A and -1D adrenergic receptor antagonists, on bladder activity in rats NeurosciLett 2002 328 74 6
20. Masuda M Nakayama K Hiromoto Y et al. Etiology of nocturia and clinical efficacy of naftopidil on nocturia in patients with benign prostatic hyperplasia-analysis of frequency Volume charts Hinyokika Kiyo 2004 50 309 14